Project Grant R01NS149623
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $178,208 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 1, 2025, through December 31, 2027. The award funds research to elucidate the critical role of the mitochondrial enzyme MDH2 (malate dehydrogenase 2) in energy metabolism...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $769,995 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded August 1, 2025, with completion scheduled for July 31, 2029. This award funds research to elucidate the functional genetic basis of KCNB1 encephalopathy, a rare developmental and epileptic...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $630,414 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025 through July 31, 2030. The award supports fundamental neuroscience research investigating sodium channel dysfunction in brain development, specifically examining how...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $634,938 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 1, 2026, through May 31, 2031. The award supports fundamental and translational research investigating RNA editing dysregulation in Dementia with Lewy Bodies (DLB) and Parkinson's...
- Federal Grant Award Summary Northwestern University received a $874,094 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025 through July 31, 2030. The research project addresses the pathophysiology of KCNQ2-related disorders, specifically investigating how mutations in the KCNQ2 gene impair the assembly and physiology of...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $214,329 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on May 6, 2026, with completion scheduled for April 30, 2028. The research will be conducted at Northwestern's Chicago, Illinois facility and investigates infection-driven...
- Federal Grant Award Summary Northwestern University's Sponsored Research Division received a $566,529 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), awarded on April 24, 2026, with completion targeted for March 31, 2031. This research initiative, conducted at Northwestern's Chicago facility, investigates age-related deficits in trophic support of...
- Federal Project Grant Award Summary Northwestern University received a $272,146 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through July 31, 2030. The award supports fundamental research investigating the spatial and temporal organization of cellular functions at membrane contact sites (MCSs)—areas where distinct cellular membranes come into close physical...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $1.15M project grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded August 1, 2025, with completion targeted for May 31, 2030. The award supports fundamental research investigating the signaling and metabolic regulation of nucleotide metabolism and cellular growth. The research program elucidates...
- Federal Project Grant Award Summary Northwestern University's Sponsored Research Division received a $498,778 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 15, 2025, with completion targeted for July 31, 2030. The research, conducted at Northwestern's Evanston, Illinois campus, focuses on mechanistic studies of ATP-binding cassette (ABC) importers in pathogenic bacteria....
Northwestern University's Sponsored Research Division received a $630,651 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective June 1, 2026 through May 31, 2031. The research focuses on elucidating the molecular mechanism of magnesium transport in neuronal homeostasis, specifically investigating the structure and transport mechanisms of the CNNM (Cyclin and CBS Domain Magnesium Transport Mediator) family of membrane proteins. These proteins are critical for maintaining cellular magnesium balance and neuronal signaling; dysfunction is associated with neurological disorders including epilepsy, developmental delay, and neurodegeneration. The project integrates high-resolution cryo-electron microscopy with biochemical and functional assays to define how CNNM proteins recognize magnesium-ATP, undergo conformational changes to mediate magnesium efflux, and sense intracellular magnesium levels. The research will also investigate how allosteric regulators, including small-molecule compounds and regulatory proteins such as PRLs (phosphatases of regenerating liver) and ARL15 (ADP-ribosylation factor-like GTPase 15), alter transporter structure and function at the molecular level. This fundamental research addresses significant gaps in understanding magnesium transport mechanisms central to nervous system health and may inform therapeutic strategies for magnesium-related neurological disorders.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $630.7k | 5/11/26 |